The Role of Animal Models in the Study of Hematopoietic Stem Cell Transplantation and GvHD: A Historical Overview

被引:36
作者
Boieri, Margherita [1 ,2 ]
Shah, Pranali [3 ]
Dressel, Ralf [3 ]
Inngjerdingen, Marit [1 ,2 ]
机构
[1] Univ Oslo, Inst Basic Med Sci, Dept Mol Med, Oslo, Norway
[2] Oslo Univ Hosp, Dept Immunol, Oslo, Norway
[3] Univ Med Ctr Gottingen, Inst Cellular & Mol Immunol, Gottingen, Germany
关键词
animal models; HSCT; aGvHD; cGvHD; pathophysiology; VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; REGULATORY T-CELLS; MESENCHYMAL STROMAL CELLS; ANTIGEN-PRESENTING CELLS; TOTAL-BODY IRRADIATION; MINOR HISTOCOMPATIBILITY BARRIERS; IDIOPATHIC PNEUMONIA SYNDROME; NECROSIS-FACTOR-ALPHA; SKIN EXPLANT MODEL;
D O I
10.3389/fimmu.2016.00333
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Bone marrow transplantation (BMT) is the only therapeutic option for many hematological malignancies, but its applicability is limited by life-threatening complications, such as graft-versus-host disease (GvHD). The last decades have seen great advances in the understanding of BMT and its related complications; in particular GvHD. Animal models are beneficial to study complex diseases, as they allow dissecting the contribution of single components in the development of the disease. Most of the current knowledge on the therapeutic mechanisms of BMT derives from studies in animal models. Parallel to BMT, the understanding of the pathophysiology of GvHD, as well as the development of new treatment regimens, has also been supported by studies in animal models. Pre-clinical experimentation is the basis for deep understanding and successful improvements of clinical applications. In this review, we retrace the history of BMT and GvHD by describing how the studies in animal models have paved the way to the many advances in the field. We also describe how animal models contributed to the understanding of GvHD pathophysiology and how they are fundamental for the discovery of new treatments.
引用
收藏
页数:20
相关论文
共 292 条
[31]   Selective Reduction of Graft-versus-Host Disease-Mediating Human T Cells by Ex Vivo Treatment with Soluble Fas Ligand [J].
Bohana-Kashtan, Osnat ;
Morisot, Sebastien ;
Hildreth, Richard ;
Brayton, Cory ;
Levitsky, Hyam I. ;
Civin, Curt I. .
JOURNAL OF IMMUNOLOGY, 2009, 183 (01) :696-705
[32]   Th1 cytokines promote T-cell binding to antigen-presenting cells via enhanced hyaluronan production and accumulation at the immune synapse [J].
Bollyky, Paul L. ;
Evanko, Stephen P. ;
Wu, Rebecca P. ;
Potter-Perigo, Susan ;
Long, S. Alice ;
Kinsella, Brian ;
Reijonen, Helena ;
Guebtner, Kelly ;
Teng, Brandon ;
Chan, Christina K. ;
Braun, Kathy R. ;
Gebe, John A. ;
Nepom, Gerald T. ;
Wight, Thomas N. .
CELLULAR & MOLECULAR IMMUNOLOGY, 2010, 7 (03) :211-220
[33]   Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease [J].
Braun, MY ;
Lowin, B ;
French, L ;
AchaOrbea, H ;
Tschopp, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (02) :657-661
[34]   Overcoming Current Limitations in Humanized Mouse Research [J].
Brehm, Michael A. ;
Shultz, Leonard D. ;
Luban, Jeremy ;
Greiner, Dale L. .
JOURNAL OF INFECTIOUS DISEASES, 2013, 208 :S125-S130
[35]   IL-21 blockade reduces graft-versus-host disease mortality by supporting inducible T regulatory cell generation [J].
Bucher, Christoph ;
Koch, Lisa ;
Vogtenhuber, Christine ;
Goren, Emily ;
Munger, Meghan ;
Panoskaltsis-Mortari, Angela ;
Sivakumar, Pallavur ;
Blazar, Bruce R. .
BLOOD, 2009, 114 (26) :5375-5384
[36]   IFNγ differentially controls the development of idiopathic pneumonia syndrome and GVHD of the gastrointestinal tract [J].
Burman, Angela C. ;
Banovic, Tatjana ;
Kuns, Rachel D. ;
Clouston, Andrew D. ;
Stanley, Amanda C. ;
Morris, Edward S. ;
Rowe, Vanessa ;
Bofinger, Helen ;
Skoczylas, Renae ;
Raffelt, Neil ;
Fahy, Olivier ;
McColl, Shaun R. ;
Engwerda, Christian R. ;
McDonald, Kelli P. A. ;
Hill, Geoffrey R. .
BLOOD, 2007, 110 (03) :1064-1072
[37]   Transfer of aflogeneic CD62L- memory T cells without graft-versus-host disease [J].
Chen, BJ ;
Cui, XY ;
Sempowski, GD ;
Liu, CX ;
Chao, NJ .
BLOOD, 2004, 103 (04) :1534-1541
[38]   Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease [J].
Chen, Xiao ;
Das, Rupali ;
Komorowski, Richard ;
Beres, Amy ;
Hessner, Martin J. ;
Mihara, Masahiko ;
Drobyski, William R. .
BLOOD, 2009, 114 (04) :891-900
[39]   Murine models of chronic graft-versus-host disease: Insights and unresolved issues [J].
Chu, Yu-Waye ;
Gress, Ronald E. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (04) :365-378
[40]  
CLAMAN HN, 1985, CELL IMMUNOL, V94, P73, DOI 10.1016/0008-8749(85)90086-3